- Home
- WOK vs CPIX Comparison
WOK vs CPIX Comparison
Compare WOK & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOK
- CPIX
- Stock Information
- Founded
- WOK 2002
- CPIX 1999
- Country
- WOK China
- CPIX United States
- Employees
- WOK N/A
- CPIX N/A
- Industry
- WOK
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- WOK
- CPIX Health Care
- Exchange
- WOK NYSE
- CPIX Nasdaq
- Market Cap
- WOK 70.3M
- CPIX 68.7M
- IPO Year
- WOK 2024
- CPIX 2009
- Fundamental
- Price
- WOK $1.07
- CPIX $5.31
- Analyst Decision
- WOK
- CPIX
- Analyst Count
- WOK 0
- CPIX 0
- Target Price
- WOK N/A
- CPIX N/A
- AVG Volume (30 Days)
- WOK 6.1M
- CPIX 4.3M
- Earning Date
- WOK 02-03-2025
- CPIX 03-07-2025
- Dividend Yield
- WOK N/A
- CPIX N/A
- EPS Growth
- WOK N/A
- CPIX N/A
- EPS
- WOK N/A
- CPIX N/A
- Revenue
- WOK $11,506,440.00
- CPIX $36,785,442.00
- Revenue This Year
- WOK N/A
- CPIX N/A
- Revenue Next Year
- WOK N/A
- CPIX N/A
- P/E Ratio
- WOK N/A
- CPIX N/A
- Revenue Growth
- WOK N/A
- CPIX N/A
- 52 Week Low
- WOK $0.85
- CPIX $1.04
- 52 Week High
- WOK $8.45
- CPIX $7.19
- Technical
- Relative Strength Index (RSI)
- WOK N/A
- CPIX 61.57
- Support Level
- WOK N/A
- CPIX $4.12
- Resistance Level
- WOK N/A
- CPIX $7.19
- Average True Range (ATR)
- WOK 0.00
- CPIX 0.99
- MACD
- WOK 0.00
- CPIX 0.12
- Stochastic Oscillator
- WOK 0.00
- CPIX 63.21
About WOK WORK MEDICAL TECHNOLOGY GROUP LTD
WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.